NCT01132547 · BASELINE
Baseline characteristics
Results reported by the registry submitting party. Population, time horizon, units and missing values must be read together.
- denoms
- counts
- group Id
- BG000
- value
- 9
- group Id
- BG001
- value
- 13
- group Id
- BG002
- value
- 22
- units
- Participants
- groups
- description
- Patients receive oral cyproheptadine hydrochloride twice daily for 8 weeks. cyproheptadine hydrochloride: Given orally
- id
- BG000
- title
- Arm I Cyproheptadine Hydrochloride
- description
- Patients receive an oral placebo twice daily for 8 weeks. placebo: Given orally
- id
- BG001
- title
- Arm II Placebo
- description
- Total of all reporting groups
- id
- BG002
- title
- Total
- measures
- classes
- categories
- measurements
- group Id
- BG000
- spread
- 5.7
- value
- 10.2
- group Id
- BG001
- spread
- 4.7
- value
- 12.0
- group Id
- BG002
- spread
- 5.1
- value
- 11.2
- dispersion Type
- STANDARD_DEVIATION
- param Type
- MEAN
- title
- Age, Continuous
- unit Of Measure
- years
- classes
- categories
- measurements
- group Id
- BG000
- value
- 3
- group Id
- BG001
- value
- 10
- group Id
- BG002
- value
- 13
- title
- Female
- measurements
- group Id
- BG000
- value
- 6
- group Id
- BG001
- value
- 3
- group Id
- BG002
- value
- 9
- title
- Male
- param Type
- COUNT_OF_PARTICIPANTS
- title
- Sex: Female, Male
- unit Of Measure
- Participants
- classes
- categories
- measurements
- group Id
- BG000
- value
- 9
- group Id
- BG001
- value
- 13
- group Id
- BG002
- value
- 22
- title
- United States
- param Type
- NUMBER
- title
- Region of Enrollment
- unit Of Measure
- participants
Complete source fields
- denoms
- counts
- group Id
- BG000
- value
- 9
- group Id
- BG001
- value
- 13
- group Id
- BG002
- value
- 22
- units
- Participants
- groups
- description
- Patients receive oral cyproheptadine hydrochloride twice daily for 8 weeks. cyproheptadine hydrochloride: Given orally
- id
- BG000
- title
- Arm I Cyproheptadine Hydrochloride
- description
- Patients receive an oral placebo twice daily for 8 weeks. placebo: Given orally
- id
- BG001
- title
- Arm II Placebo
- description
- Total of all reporting groups
- id
- BG002
- title
- Total
- measures
- classes
- categories
- measurements
- group Id
- BG000
- spread
- 5.7
- value
- 10.2
- group Id
- BG001
- spread
- 4.7
- value
- 12.0
- group Id
- BG002
- spread
- 5.1
- value
- 11.2
- dispersion Type
- STANDARD_DEVIATION
- param Type
- MEAN
- title
- Age, Continuous
- unit Of Measure
- years
- classes
- categories
- measurements
- group Id
- BG000
- value
- 3
- group Id
- BG001
- value
- 10
- group Id
- BG002
- value
- 13
- title
- Female
- measurements
- group Id
- BG000
- value
- 6
- group Id
- BG001
- value
- 3
- group Id
- BG002
- value
- 9
- title
- Male
- param Type
- COUNT_OF_PARTICIPANTS
- title
- Sex: Female, Male
- unit Of Measure
- Participants
- classes
- categories
- measurements
- group Id
- BG000
- value
- 9
- group Id
- BG001
- value
- 13
- group Id
- BG002
- value
- 22
- title
- United States
- param Type
- NUMBER
- title
- Region of Enrollment
- unit Of Measure
- participants
Download exact source JSON → · Snapshot ctgov-results-25a395029948b04d52b1253f
Preserved source evidence · Not medical advice
Triangle